Dementia clinical trials in Illinois
13 studies for Dementia are looking for participants at sites in Illinois.
Cities in Illinois
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Sep 17, 2026 · NCT06976203Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
- Northwestern University, Chicago
- University of Illinois at Chicago, Chicago
- Chicago VA Medical Center/Jesse Brown VA, Chicago
- and 4 more
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216Medication Collaboration Feasibility Study
- Northwestern University, Chicago
Recruiting
Ages 60 and older · All sexes · Updated Aug 14, 2026 · NCT07742189A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT05552157A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT06647498Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 90 · All sexes · Updated Jul 14, 2026 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
RecruitingPhase 3
Ages 55 and older · All sexes · Updated Jul 7, 2026 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Jun 1, 2026 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk
- University of Chicago Medicine, Chicago
Recruiting
Ages 40 to 58 · Women · Updated Feb 5, 2026 · NCT06965686Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
- Loyola University, Chicago
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jan 15, 2026 · NCT05677880Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Dec 14, 2023 · NCT06170268From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.